GlaxoSmithKline PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.

GSK completes sale of shares in Haleon plc

GSK announces intention to sell shares in Haleon

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

GlaxoSmithKline PLC (GSK LN)

GSK completes sale of shares in Haleon plc

GSK announces intention to sell shares in Haleon

Director/PDMR Shareholding

Result of AGM

Board Committee Change

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)